MedPath

Clinical study of the usefulness of MMC intravesical infusion therapy soon after nephroureterectomy in patients with urothelial carcinoma of upper urinary tract

Not Applicable
Conditions
upper urinary tract urotherial tumors.
Registration Number
JPRN-UMIN000020365
Lead Sponsor
Asahikawa medical univercity department of Urology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
52
Inclusion Criteria

Not provided

Exclusion Criteria

1.Both upper urinary tract urotherial tumor 2.History of bladder tumor 3.history of neo-adjuvant chemotherapy 4.Patient can't voiding

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Bladder recurrence rate Evaluated at the cystoscope of every three months after the administration , conduct the longest two years observation
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath